Company Profile
Johnson & Johnson Stock Price, News & Analysis
- Ticker:
- JNJ
- Exchange:
- NYSE
- Sector:
- Biopharma, Small Molecule Drugs, Nucleic Acid Drugs, Novel Therapies
- Location:
- United States
Stock performance
256.98 USD (-0.24%)
Close
Last updated: August 6, 2026
537B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, JNJ was little changed and closed at $256.98. No new same-company headline was identified in the current news window.
Company overview
Business overview
Johnson & Johnson is a global healthcare leader spanning innovative medicines and medtech. Its scale, diversification, and broad therapeutic reach make it one of the most important names in the sector.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, J&J has a global footprint across pharmaceuticals and medical devices. It is a diversified healthcare company rather than a pure biotech or single-segment platform.
Business Model Characteristics
The company generates value through product sales across medicines, surgery, orthopedics, and medtech franchises. Investors focus on pipeline depth, launch execution, and the ability to replace mature products with new growth drivers.
Position Within the Biotechnology Landscape
J&J sits above the biotech cycle as a diversified healthcare bellwether. It is less volatile than development-stage biotech, but regulatory and pipeline updates still matter because they shape long-term growth expectations.
Future catalysts
Johnson & Johnson’s near-term watchpoints are the TAR-210 uro-oncology program, RYBREVANT FASPRO rollout, and any further updates that show whether the company can keep turning new assets into commercial momentum. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Johnson & Johnson (JNJ)?
Johnson & Johnson (JNJ) most recently closed at 256.98 USD, a -0.24% move versus the previous session.
What is the market cap of Johnson & Johnson (JNJ)?
Johnson & Johnson currently has a market capitalization of 537B USD on BioPharmSignal.
What does Johnson & Johnson do?
Johnson & Johnson is a global healthcare leader spanning innovative medicines and medtech. Its scale, diversification, and broad therapeutic reach make it one of the most important names in the sector.
On which exchange is JNJ stock listed?
Johnson & Johnson (JNJ) is associated with NYSE, United States, Biopharma, Small Molecule Drugs, Nucleic Acid Drugs, Novel Therapies.
What is TAR-210?
Johnson & Johnson’s near-term watchpoints are the TAR-210 uro-oncology program, RYBREVANT FASPRO rollout, and any further updates that show whether the company can keep turning new assets into commercial momentum.
Which conditions is Johnson & Johnson targeting with TAR-210?
Johnson & Johnson is associated with oncology based on its company overview and current catalyst commentary.
How does Johnson & Johnson describe recent progress with TAR-210?
Johnson & Johnson’s near-term watchpoints are the TAR-210 uro-oncology program, RYBREVANT FASPRO rollout, and any further updates that show whether the company can keep turning new assets into commercial momentum.
What is Johnson?
Johnson & Johnson is a global healthcare leader spanning innovative medicines and medtech.